Susanne Hodgson

Susanne Hodgson is a Research Fellow and Lecturer in Clinical Medicine at St Peter’s College, University of Oxford, while also serving as an NIHR Academic Lecturer in Infectious Diseases. Her primary affiliations include the Jenner Institute and the Department of Biochemistry within the Nuffield Department of Medicine. She combines research, teaching, and clinical roles, focusing on vaccine development and infectious disease management.

She holds a Postgraduate Diploma in Learning and Teaching in Higher Education from the University of Oxford, reflecting her commitment to medical education. Her research spans early-phase clinical trials for novel vaccines against Plasmodium falciparum (malaria) and Influenza, including controlled human infection (CHIM) studies. She completed her DPhil in 2015, which involved establishing Kenya’s first CHMI facility to study naturally acquired immunity in malaria. Currently, she explores human monoclonal antibodies targeting VAR2CSA, critical for malaria during pregnancy.

In clinical practice, Susanne specializes in Microbiology, Infectious Diseases, and General Internal Medicine, particularly complex surgical infections. She leads the 'Improving Outcomes in Necrotising Otitis Externa (IONOE)' study (NCT04950985) and chairs the National Trainee Infection Collaborative for Audit and Research (NITCAR). Her teaching roles at St Peter’s College include pastoral support and coordinating the Special Study Module for Infectious Diseases, alongside co-leading the Infection and Immunity Module for the Graduate Entry Medicine Course.

While no articles are explicitly listed, her work bridges clinical research and education, emphasizing translational medicine and global health. She actively contributes to audit and research initiatives through her leadership roles in national collaboratives.